# Effect of Communicating Structured Benefit and Harm Information in European Patient Leaflets on Individuals' Expectations About Medicines

> **NCT07061197** · NA · NOT_YET_RECRUITING · sponsor: **London School of Economics and Political Science** · enrollment: 2100 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Patient leaflet with the EMA's proposed key information section including qualitative statements.
- **OTHER:** Control (standard patient leaflet)
- **OTHER:** Patient leaflet with a key information section providing both qualitative and quantitative information on drug benefits and harms.

## Key facts

- **NCT ID:** NCT07061197
- **Lead sponsor:** London School of Economics and Political Science
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07061197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07061197, "Effect of Communicating Structured Benefit and Harm Information in European Patient Leaflets on Individuals' Expectations About Medicines". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07061197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*